Valuation: Integrum AB

Market Cap 21Cr 2.14Cr 1.85Cr 1.75Cr 1.59Cr 2.98Cr 205.18Cr 3Cr 8.04Cr 104.04Cr 8.03Cr 7.86Cr 331.8Cr P/E 2024
260x
P/E 2025 -8.99x
Enterprise Value 17Cr 1.78Cr 1.54Cr 1.46Cr 1.32Cr 2.48Cr 171.08Cr 2.5Cr 6.71Cr 87Cr 6.7Cr 6.55Cr 276.64Cr EV / Sales 2024
10x
EV / Sales 2025 2.82x
Free-Float
69.65%
Yield 2024 *
-
Yield 2025 -
1 day-3.50%
1 week-2.75%
Current month+0.34%
1 month+5.75%
3 months+6.64%
6 months+11.35%
Current year-17.94%
1 week 8.5
Extreme 8.5
9.2
1 month 8
Extreme 8
10.18
Current year 6.4
Extreme 6.4
10.84
1 year 6.4
Extreme 6.4
26.65
3 years 6.4
Extreme 6.4
64
5 years 6.4
Extreme 6.4
104.6
10 years 5.3
Extreme 5.3
104.6
Manager TitleAgeSince
Chief Executive Officer 48 05/05/2025
Chief Executive Officer 66 19/05/2022
Director of Finance/CFO - 15/09/2025
Director TitleAgeSince
Chairman 66 -
Director/Board Member 65 01/01/2025
Director/Board Member 74 01/01/2025
Date Insider Type Main position Quantity % Market Cap. Importance
20/12/25 Buy

Chief Executive Officer

13,001 0.0503%
21/10/24 Buy

Chief Technology Officer

10,000 0.0562%
30/08/24 Buy

Chief Financial Officer

1,250 0.0070%
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-2.75%-79.37%-63.81% 2.41Cr
+0.65%+2.54%+5.82%-25.76% 1.87TCr
-0.61%-1.30%-2.44%+1.78% 1.66TCr
+0.43%+1.26%-54.63%-47.00% 636.31Cr
-2.71%-6.27% - - 397.45Cr
-1.93%-10.04%+28.15%+56.84% 192.26Cr
0.00%-4.39%-10.82%-9.33% 178.7Cr
-1.01%-7.45%-51.74%-63.02% 107.3Cr
+3.42%+2.29%+45.54%+158.42% 91Cr
-1.64%+0.56%+51.55%+260.94% 56Cr
Average -0.45%-2.90%-7.55%+29.90% 518.41Cr
Weighted average by Cap. +0.04%-0.92%-4.84%-9.14%

Financials

2024 2025
Net sales 10Cr 1.07Cr 92.27L 87.25L 78.99L 1.48Cr 102.18Cr 1.49Cr 4.01Cr 52Cr 4Cr 3.91Cr 165.23Cr 9.11Cr 93.2L 80.73L 76.34L 69.11L 1.3Cr 89Cr 1.31Cr 3.5Cr 45Cr 3.5Cr 3.42Cr 144.57Cr
Net income 40.32L 4L 4L 3L 3L 6L 3.96Cr 6L 15.51L 2.01Cr 15.5L 15.15L 6.4Cr -3.08Cr -31.53L -27.31L -25.82L -23.38L -43.88L -30Cr -44.21L -1.19Cr -15Cr -1.18Cr -1.16Cr -49Cr
Net Debt -1.05Cr -10.72L -9L -9L -8L -14.92L -10Cr -15.03L -40.31L -5.21Cr -40.26L -39.37L -17Cr -3.48Cr -35.56L -30.8L -29.12L -26.37L -49.49L -34Cr -49.86L -1.34Cr -17Cr -1.34Cr -1.31Cr -55Cr
Logo Integrum AB
Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
Employees
33
Date Price Change Volume
15/26/15 SEK 8.830 -3.50% 3,029
14/26/14 SEK 9.150 -0.54% 13,473
11/26/11 SEK 9.200 +3.95% 32,255
10/26/10 SEK 8.850 +1.03% 9,775
09/26/09 SEK 8.760 -3.52% 33,128

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INTEG B Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!